[{"address1": "5959 Horton Street", "address2": "7th Floor", "city": "EmeryVille", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 871 4880", "website": "https://metagenomi.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Metagenomi Therapeutics, Inc. a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in EmeryVille, California.", "fullTimeEmployees": 124, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jian  Irish M.B.A., Ph.D.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 734626, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian Charles Thomas Ph.D.", "age": 56, "title": "Co-Founder & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 913299, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pamela M. Wapnick M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 581813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Knowles M.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Leonard", "title": "Senior Vice Pres\u00adi\u00addent of Tech\u00adni\u00adcal Devel\u00adop\u00adment & Oper\u00ada\u00adtions", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew L. Wein J.D.", "age": 53, "title": "Senior VP, Head of Legal, Compliance Officer & Corporate Secretary", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Brooks Ph.D.", "age": 59, "title": "Senior Vice President of Research", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Katalin  Kauser M.D., Ph.D.", "title": "Senior Vice Pres\u00adi\u00addent of Trans\u00adla\u00adtion\u00adal Biol\u00ado\u00adgy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.75, "open": 1.76, "dayLow": 1.68, "dayHigh": 1.8, "regularMarketPreviousClose": 1.75, "regularMarketOpen": 1.76, "regularMarketDayLow": 1.68, "regularMarketDayHigh": 1.8, "payoutRatio": 0.0, "forwardPE": -0.9260274, "volume": 193969, "regularMarketVolume": 193969, "averageVolume": 385154, "averageVolume10days": 281700, "averageDailyVolume10Day": 281700, "bid": 1.66, "ask": 1.74, "bidSize": 1, "askSize": 1, "marketCap": 63454012, "fiftyTwoWeekLow": 1.23, "fiftyTwoWeekHigh": 3.95, "allTimeHigh": 12.74, "allTimeLow": 1.23, "priceToSalesTrailing12Months": 2.0526643, "fiftyDayAverage": 1.7077, "twoHundredDayAverage": 1.92215, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -78996992, "profitMargins": -2.8705702, "floatShares": 27252934, "sharesOutstanding": 37546751, "sharesShort": 2208088, "sharesShortPriorMonth": 1609444, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0588, "heldPercentInsiders": 0.29292, "heldPercentInstitutions": 0.17201, "shortRatio": 5.85, "shortPercentOfFloat": 0.080699995, "impliedSharesOutstanding": 37546751, "bookValue": 4.753, "priceToBook": 0.35556492, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -88738000, "trailingEps": -2.39, "forwardEps": -1.825, "enterpriseToRevenue": -2.555, "enterpriseToEbitda": 0.91, "52WeekChange": -0.38989168, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 1.69, "targetHighPrice": 12.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.33333, "targetMedianPrice": 9.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 184114000, "totalCashPerShare": 4.904, "ebitda": -86791000, "totalDebt": 41663000, "quickRatio": 6.3, "currentRatio": 6.417, "totalRevenue": 30913000, "debtToEquity": 23.348, "revenuePerShare": 0.831, "returnOnAssets": -0.19023001, "returnOnEquity": -0.40872002, "grossProfits": -65183000, "freeCashflow": -55426124, "operatingCashflow": -91622000, "revenueGrowth": -0.248, "grossMargins": -2.1086, "ebitdaMargins": -2.80759, "operatingMargins": -2.6376002, "financialCurrency": "USD", "symbol": "MGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Metagenomi Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1769211067, "regularMarketTime": 1769202000, "exchange": "NMS", "messageBoardId": "finmb_633445224", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.42857, "regularMarketPrice": 1.69, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1707489000000, "postMarketChangePercent": 0.58579725, "postMarketPrice": 1.6999, "postMarketChange": 0.009899974, "regularMarketChange": -0.0599999, "regularMarketDayRange": "1.68 - 1.8", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 385154, "fiftyTwoWeekLowChange": 0.46000004, "fiftyTwoWeekLowChangePercent": 0.37398377, "fiftyTwoWeekRange": "1.23 - 3.95", "fiftyTwoWeekHighChange": -2.26, "fiftyTwoWeekHighChangePercent": -0.5721519, "fiftyTwoWeekChangePercent": -38.98917, "earningsTimestampStart": 1755115200, "earningsTimestampEnd": 1755115200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.39, "epsForward": -1.825, "epsCurrentYear": -2.3375, "longName": "Metagenomi Therapeutics, Inc.", "priceEpsCurrentYear": -0.7229946, "fiftyDayAverageChange": -0.017699957, "fiftyDayAverageChangePercent": -0.010364793, "twoHundredDayAverageChange": -0.23214996, "twoHundredDayAverageChangePercent": -0.12077619, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-02-09", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Metagenomi Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]